Case Report: Iptacopan combined with intensive immunosuppressive therapy in an older adult patient with severe aplastic anemia and paroxysmal nocturnal hemoglobinuria
Year: 2026
Type: article
Study design: Case Report
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disorder. Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard of care as frontline treatment if a donor is available in younger patients with SAA regardless the presence of a PNH clone. However, older adult patients with SAA face high risks of infection and bleeding, poor treatment tolerance, and suboptimal overall survival after transplantation. Current guidelines recommend intensive immunosuppressive therapy (IST) as the frontline approach for older adult SAA. Here, we report a case of an older adult patient with SAA and PNH who received IST combined with iptacopan, resulting in significant improvement in both disease status and quality of life.
Source: Frontiers in Immunology
Authors: Ting Zhang(Conceptualization, Funding acquisition, Investigation, Resources, Writing – original draft, Writing – review & editing), Yongchao Ma(Data curation, Writing – original draft, Writing – review & editing), Chengtao Qin(Investigation, Software, Writing – original draft, Writing – review & editing), Yuemin Gong(Methodology, Validation, Writing – original draft, Writing – review & editing), Yawen Zhang(Methodology, Validation, Writing – original draft, Writing – review & editing), Guangsheng He(Project administration, Supervision, Writing – original draft, Writing – review & editing), Jinning Shi(Methodology, Resources, Writing – original draft, Writing – review & editing)
Institutions: Nanjing Jiangning Hospital, Jiangsu Province Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236125059
